Ana M. Ferreira
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 144 publications
Bioprinting chondrocyte hydrogel cultures onto fibre membranes for cartilage defect repair.
Journal: Biomaterials science
Published: June 19, 2026
Bone-like Collagen Matrices Through Rapid Intrafibrillar Mineralisation.
Journal: Journal of functional biomaterials
Published: May 27, 2026
Fully automated analysis of cardiotoxicity surveillance echocardiograms: a direct test-retest precision comparison with experts.
Journal: European heart journal. Imaging methods and practice
Published: May 15, 2026
Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study.
Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
Published: May 10, 2026
Stereotactic radiotherapy in oligometastatic prostate cancer: a single-center experience.
Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
Published: April 12, 2026
Effect of bio-ink physical properties on droplet volume in the reactive jet impingement 3D bioprinting system.
Journal: Journal of the mechanical behavior of biomedical materials
Published: March 31, 2026
Bioprinting High-Cell-Density Cardiac Tissue Constructs With Sustained Contractile Function.
Journal: Advanced healthcare materials
Published: March 16, 2026
A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer.
Journal: Investigational new drugs
Published: February 04, 2026
Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer.
Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
Published: December 14, 2025
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 24, 2025
Last Updated: 09/26/2026